Skip to content
Peptide research

PEG-MGF

Also known as PEGylated Mechano Growth Factor
Category
Tissue Repair & Recovery
Administration routes
Injectable
Regulatory status
Not FDA-approved

What it is

A PEGylated MGF-related peptide intended to prolong exposure; sustained muscle-repair effects after training have not been established. The case rests entirely on animal and cell studies, and one even found no effect on muscle stem cells. It has never been tested in a human trial, leaving essentially no human safety data and an unresolved, IGF-1-related tumor concern. Not an approved drug in the US; products sold online are unregulated and of uncertain purity.

Read Full record

Studied uses & evidence

Studied uses(7)

  • Muscle satellite cell activation and skeletal muscle repair

    Low

    Animal and cell studies suggest satellite cell activation, but one 2014 study found none. No human data.

  • Cardioprotection and reduced cardiac damage after myocardial infarction

    Low

    Consistent across mouse and sheep heart attack models, reducing cell death, with no human trials yet.

  • Neuroprotection and promotion of neurogenesis in the aging brain

    Low

    Mouse studies show new neuron growth and reduced brain injury in aging models, no human data.

Evidence limits

Evidence Level
Preclinical

The cited therapeutic evidence concerns native MGF, synthetic E-domain peptides, gene overexpression or peptide-loaded scaffolds. It is preclinical background and does not establish the effects of PEG-MGF itself. These studies used cell culture and animal models, including mice, rats, rabbits and sheep. Human data are limited to observational studies measuring endogenous MGF/IGF-1Ec mRNA expression in human muscle biopsies after exercise or injury, and in vitro studies using human-derived muscle progenitor cells treated with synthetic MGF peptide (Kandalla et al. 2011). No interventional human trial has administered PEG-MGF or MGF E-domain peptide to human subjects. The preclinical evidence is robust in cardiac protection models but actively contested in skeletal muscle (Fornaro et al. 2014 contradicted satellite cell activation claims). Anti-doping labs have developed detection methods for MGF (Thevis et al. 2014), indicating known illicit use in athletes despite absence of clinical validation.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Active cancer

    High

    Growth factor activity may promote tumor cell proliferation.

General cautions

  • Pregnancy

    Absolute

    No safety data. Growth factor modulation during pregnancy is dangerous.

Risk summary(6)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Never administered to humans in a controlled clinical trial

    High
  • Fornaro et al. 2014 found no effect of MGF peptide on myoblasts/muscle stem cells (efficacy debated)

    Moderate
  • IGF-1-related; could theoretically accelerate tumor proliferation

    Theoretical
  • Unregulated products sold online

    High
  • Injection site pain/numbness/redness (anecdotal)

    Low
  • May lower blood glucose; hypoglycemia risk with diabetes meds

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.